{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:01:38Z","timestamp":1766516498415,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.urolonc.2020.03.015","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:16:49Z","timestamp":1586909809000},"page":"793.e13-793.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of \u201creal life\u201d prostate MRI inter-observer variability on total needle samples and indication for biopsy"],"prefix":"10.1016","volume":"38","author":[{"given":"Barak","family":"Rosenzweig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Laitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorit E","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orit","family":"Raz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Ramon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohar A","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orith","family":"Portnoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.03.015_bib0001","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0002","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2014.11.037","article-title":"Magnetic resonance imaging\u2013targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis","volume":"68","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0003","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1148\/radiol.2452061983","article-title":"Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN\/GOG comparative study of diagnostic performance and interobserver variability","volume":"245","author":"Hricak","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00066-003-0976-5","article-title":"The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences","volume":"179","author":"Weiss","year":"2003","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0006","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brachy.2017.09.015","article-title":"Interobserver variability in rectum contouring in high-dose-rate brachytherapy for prostate cancer: a multi-institutional prospective analysis","volume":"17","author":"Chicas-Sett","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0007","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/radiol.2015142818","article-title":"Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging","volume":"277","author":"Muller","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0008","unstructured":"NCCN Guidelines version 2.2018. Prostate cancer early detection2018.https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate_detection.pdf."},{"key":"10.1016\/j.urolonc.2020.03.015_bib0009","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1002\/cncr.28216","article-title":"Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer","volume":"119","author":"Stamatakis","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0010","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/cncr.30548","article-title":"Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population","volume":"123","author":"Lai","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0011","first-page":"202.e1","article-title":"Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance","volume":"33","author":"Walton Diaz","year":"2015","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0012","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.16.16876","article-title":"The learning curve in prostate MRI interpretation: self-directed learning versus continual reader feedback","volume":"208","author":"Rosenkrantz","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0013","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00330-009-1625-x","article-title":"Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer","volume":"20","author":"Akin","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0014","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bju.12892","article-title":"Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool","volume":"117","author":"Gaziev","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0015","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s11255-018-1986-7","article-title":"A negative multiparametric magnetic resonance imaging finding does not guarantee the absence of significant cancer among biopsy-proven prostate cancer patients: a real-life clinical experience","volume":"50","author":"Kim","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0016","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5152\/tud.2018.12144","article-title":"PI-RADS v2: current standing and future outlook","author":"Smith","year":"2018","journal-title":"T\u00fcrk \u00dcroloji Dergisi\/Turkish J Urol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0017","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2016152542","article-title":"Interobserver reproducibility of the PI-RADS version 2 Lexicon: a multicenter study of six experienced prostate radiologists","volume":"280","author":"Rosenkrantz","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0018","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12894-016-0132-z","article-title":"Abiraterone acetate in metastatic castration-resistant prostate cancer \u2013 the unanticipated real-world clinical experience","volume":"16","author":"Poon","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0019","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1093\/annonc\/mdt397","article-title":"Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials","volume":"24","author":"Templeton","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clgc.2018.10.006","article-title":"Multiparametric magnetic resonance imaging second opinion may reduce the number of unnecessary prostate biopsies: time to improve radiologists\u2019 training program?","volume":"17","author":"Luzzago","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13244-017-0578-x","article-title":"An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines","volume":"9","author":"Panebianco","year":"2018","journal-title":"Insights Imaging"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2214\/AJR.13.10699","article-title":"Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI","volume":"202","author":"Rosenkrantz","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0023","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.juro.2015.11.055","article-title":"Serial magnetic resonance imaging in active surveillance of prostate cancer: incremental value","volume":"195","author":"Felker","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189272","article-title":"Repeat multiparametric MRI in prostate cancer patients on active surveillance","volume":"12","author":"Eineluoto","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11934-015-0507-9","article-title":"The role of MRI in active surveillance for prostate cancer","volume":"16","author":"Fascelli","year":"2015","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0026","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","article-title":"Artificial intelligence in radiology","volume":"18","author":"Hosny","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0027","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s41747-019-0109-2","article-title":"Machine learning applications in prostate cancer magnetic resonance imaging","volume":"3","author":"Cuocolo","year":"2019","journal-title":"Eur Radiol Exp"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0028","unstructured":"Andriole G, Bahnson RR, Carlsson S, Castle EP, Catalona WJ, Robert Lurie \u03c9H, et al. NCCN guidelines version 1.2019 prostate cancer early detection. 2019."},{"key":"10.1016\/j.urolonc.2020.03.015_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201384","article-title":"Optimizing patient's selection for prostate biopsy: a single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer","volume":"13","author":"Punnen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.04.057","article-title":"Prospective evaluation of the prostate imaging reporting and data system version 2 for prostate cancer detection","volume":"196","author":"Mertan F","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0031","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.crad.2016.01.001","article-title":"Predictive value of PI-RADS classification in MRI-directed transrectal ultrasound guided prostate biopsy","volume":"71","author":"NiMhurchu","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0032","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2020.03.015_bib0033","first-page":"202.e1","article-title":"Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance","volume":"33","author":"Walton Diaz","year":"2015","journal-title":"Urol Oncol Semin Orig Investig"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920301022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920301022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:18:44Z","timestamp":1761041924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920301022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1078143920301022"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.03.015","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of \u201creal life\u201d prostate MRI inter-observer variability on total needle samples and indication for biopsy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}